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While morphological and molecular events during angiogenesis in brain glioma have been extensively studied, the functional
properties of tumour vessels have yet received little attention. We have determined changes in regional blood volume (BV) during
graded hypoxic hypoxia using susceptibility contrast magnetic resonance imaging in a model of rat brain glioma. Nine anaesthetised
and ventilated rats with C6 glioma were subjected to incremental reduction in the fraction of inspired oxygen (FiO2): 0.35, 0.25, 0.15,
0.12, 0.10 and reoxygenation to 0.35. At each episode, BV was determined in peritumoral, intratumoral and contralateral regions.
Baseline BV values (FiO2 of 0.35) were higher in peritumoral than in the contralateral and intratumoral regions. Progressive hypoxia
resulted in a graded increase in BV in contralateral and peritumoral regions. At FiO2 of 0.10, BV increases were comparable between
these two regions: 49722% (s.d.) and 28717% with respect of control values, respectively. These BV changes reversed during the
reoxygenation episode. By contrast, the intratumoral region had a significant increase in BV at FiO2 of 0.10 only, with no evidence of
return to the basal value during reoxygenation. Immunohistochemical staining of a-smooth muscle actin confirmed reactivity of
vessels in the peritumoral region. Our findings indicate that peritumoral vessels present a vascular reactivity to hypoxia, which is
comparable to that of nontumoral vessels. A method is thus available for noninvasively demonstrating whether any particular vascular
modifying strategy results in the desired outcome in terms of tumour blood volume changes.
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Mechanisms of brain glioma proliferation have been extensively
studied. This tumour grows initially by cooptation of existing host
vessels (Holash et al, 1999). In a second phase, the host vessels
regress, leading to a secondary avascular tumour and eventually to
angiogenesis. The switch to an angiogenic phenotype results from
a positive balance between proangiogenic factors, for example,
vascular endothelium growth factor (VEGF) and antiangiogenic
factors (Folkman and Klagsbrun, 1987). Hypoxia may play a major
role in the induction of the angiogenic switch (Shweiki et al, 1992),
as hypoxic perinecrotic regions and VEGF expression have been
closely related (Damert et al, 1997; Rofstad and Danielsen, 1999).
Vascular endothelium growth factor produced in the hypoxic
region induces formation of neovessels in the peritumoral region.
Three regions can be thus distinguished during advanced
development of brain glioma: a central region with necrosis and
no vessels; a peritumoral region with a high degree of angiogen-
esis, including tumour tissue and nontumour tissue at the edge of
the tumour and containing tumour cells; and an intermediate
region with large, tortuous and pleomorphic vessels (Deane and
Lantos, 1981; Zama et al, 1991).
Few studies have been aimed at investigating the functional
properties of the vessels in brain glioma (Mazurchuk et al,
1999). Yet, the possibility to enhance local blood flow in the
tumoral tissue presents interest in view of enhancing drug delivery
to the tumoral tissue. One way to explore the cerebro-
vascular reactivity is to measure blood volume (BV) response to
hypoxic hypoxia (low PaO2), which is a potent vasodilator in
brain (Kontos et al, 1978). We recently measured regional cerebral
BV response to hypoxic hypoxia in normal rats, using suscept-
ibility contrast magnetic resonance imaging (MRI) (Julien-Dolbec
et al, 2002). By measuring BV response to hypoxic hypoxia
in a model of rat brain glioma, our goal was to assess overall
vessel reactivity to hypoxia in those tumours and to determine
possible differences in responsiveness between intratumoral,
peritumoral and nontumoral areas. We defined peritumoral region
as the region at the edge of the tumour having the largest BV due
to a high vessel density.
MATERIALS AND METHODS
Animal preparation
Animals were prepared in accordance with the guidelines of
the French Government (decree No. 87–848 of 19 October
1987, licenses 006683 and A38071) and with the UKCCCR
Guidelines for the Welfare of Animals in Experimental Neoplasia
(Workman et al, 1998). A total of 26 Wistar female rats
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s(160–180g) were studied. For the purpose of tumour implan-
tation, rats were anaesthetised with an intraperitoneal injection
of chloral hydrate (400mgkg
 1). A cell suspension of C6 glioma
(10
5 cells in 5ml of a culture medium without foetal calf serum)
was stereotaxically injected using a Hamilton syringe through
a burr hole (1mm diameter) in the right striatum (7mm
anterior to the zero ear bars, 3mm right to the midline, 3mm
depth from the dura). The C6 glioma cell line was established by
Benda et al (1971) from a methyl-nitrosourea-induced rat
glioma. The C6 cells were cultured in Dulbeco’s modified Eagle’s
medium (DMEM, GilboBRL, Lifes technologies, Scotland)
supplemented with 10% foetal calf serum (GilboBRL, Lifes
technologies, Scotland), 50Uml
 1 penicillin and 50mgml
 1
streptomycin.
The MRI study was performed during the 4th week after tumour
implantation, so that significant tumour growth and brain
neovessels could be observed (Peoc’h et al, 1999). Anaesthesia
was induced with 4% halothane and then maintained with an
intraperitoneal injection of thiopental (20mgkg
 1). In total, 1%
lidocaine was injected subcutaneously for local anaesthesia at
all surgical sites. After tracheostomy, rats were mechanically
ventilated with 65% nitrous oxide–35% oxygen using a rodent
ventilator (Model 683, Harvard Apparatus Inc., South Natick,
MA, USA). Ventilation was adjusted to maintain partial arterial
CO2 pressure (PaCO2)a tE35mmHg. The fraction of inspired
oxygen (FiO2) was continuously monitored (MiniOX I analyser,
Catalyst Research Corporation, Owings Mills, MD, USA). A
0.7-mm indwelling catheter was inserted into the left femoral
artery to monitor mean arterial blood pressure (MABP) via a chart
recorder (8000S, Gould Electronic, Ballainvilliers, France).
Blood gases (PaO2 and PaCO2), arterial saturation of haemo-
globin in oxygen (SaO2), arterial pH (pHa) and haemoglobin
content (Hb) were analysed from less than 0.1ml arterial
blood samples (ABL 510, Radiometer, Copenhagen, Denmark).
Another 0.7-mm indwelling catheter was inserted into the left
femoral vein to continuously infuse a normal saline solution
containing epinephrine (25ngmin
 1) and sodium bicarbonate
(0.4mmolmin
 1) at a rate of 2mlh
 1 throughout the study.
Epinephrine was required to protect from the adverse effects
of combined anaesthesia and hypoxic hypoxia on the cardiovas-
cular system. Sodium bicarbonate was used to prevent arterial
acidosis. Canulation of the femoral vein was also required for
the injection of the contrast agent. Rectal temperature was
maintained at 37.570.51C by using a heating pad placed under
the abdomen.
Experimental protocol
Animals were subjected to a stepwise lowered FiO2: control episode
(FiO2 of 0.35), normoxia episode (FiO2 of 0.25), hypoxic episodes
(FiO2 of 0.15, 0.12 and 0.10) and reoxygenation episode (FiO2 of
0.35) (Figure 1). The basic cycle started after a 30min equilibration
episode at FiO2 of 0.35 (control). The initial criteria for exclusion
from the study were: MABP o100mmHg, pHa o7.30, PaO2
o100mmHg, Hb o10gdl
 1. The subsequent episodes were then
first induced by lowering the inhaled oxygen for FiO2¼0.25, then
by replacing the oxygen by air (FiO2 of 0.15 and 0.12). During
these four episodes, fractions of inspired nitrous oxide were 0.65,
0.75, 0.25 and 0.40, respectively. Reoxygenation was obtained by
restoring the oxygen in the gas mixture. Each FiO2 episode
(normoxia, hypoxia and reoxygenation) lasted 10min: a 4min
equilibrium period followed by MRI acquisition and determination
of MABP and arterial blood sampling. If MABP o70mmHg, pHa
o7.30 or PaCO2 o27mmHg at FiO2 of 0.25, 0.15 and 0.12, the
animal was excluded from the study. No exclusion criterion was
applied at FiO2 of 0.10 (severe hypoxia) and during the
reoxygenation episode. When the cycle of measurements ended,
rats were killed by administration of an overdose of thiopental
(50mgkg
 1). Brains were excised from the skull for histological
study, and frozen in isopentane at  501C and stored at  801C.
Magnetic resonance imaging measurement
Magnetic resonance imaging was performed with a 2.35T, 40-cm
diameter horizontal bore magnet (Bruker Spectrospin, Wissen-
bourg, France) equipped with a 20-cm diameter actively shielded
gradient (Magnex Scientific Ltd, Adingdon, UK) and with a SMIS
console (SMIS Ltd, Guildford, UK). The rat was lying prone, its
head secured via ear bars. A 30-mm diameter surface coil was
located directly above the brain. After radiofrequency coil
matching and tuning, the magnetic field homogeneity was adjusted
to obtain a linewidth for water smaller than 0.5 part per million in
the brain. Six adjacent horizontal slices (from 2mm below bregma)
were chosen from a coronal T1-weighted image. A series of T2*-
weighted images for each slice was acquired at different echo times
using a multigradient-echo sequence with an echo spacing interval
of 4.2ms (repetition time TR¼2,000ms; first echo time
TE¼7.6ms; 64 32 data acquisition image matrix; number of
averages¼2; field of view¼35 35mm
2; slice thickness¼1mm;
number of slices¼6). Acquisition of all images of the six slices
took about 3min.
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Figure 1 Experimental protocol for the BV measurements in rat brain tumour during graded hypoxic hypoxia. Magnetic resonance imaging was
performed before injection of contrast agent at the beginning of the control episode. Postcontrast MRI, mean arterial blood pressure (MABP) measurement
and arterial blood gas analysis were performed 4min after onset of each FiO2 level.
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sA superparamagnetic iron oxide contrast agent was intrave-
nously injected (200mmol of iron per kg body mass of AMI-227,
Sinerem
s; Guerbet, Aulnay-sous-Bois, France) 30min after the
start of the experiment (FiO2 of 0.35). Images were acquired before
(n¼24 echoes, precontrast image) and 3min after injection
(n¼12 echoes, postcontrast image). Acquisition of postcontrast
images was then repeated at the end of each subsequent FiO2
episode (FiO2 of 0.25, 0.15, 0.12 and 0.10, and reoxygenation).
Magnetic resonance imaging analysis
Image processing and determination of BV were performed using
an Ultrasparc workstation (Sun Microsystems, Pasadena, CA,
USA). Susceptibility contrast MRI exploits the increase in the
magnetic susceptibility difference (Dw) between the intravascular
and the extravascular compartments induced by the presence of a
long-lived intravascular contrast agent. This increase in Dw results
in an increase DR2* of the transverse decay rate (R2*¼1/T2*) of
the NMR signal from the water protons. DR2* is proportional to
BV as previously shown (Yablonskiy and Haacke, 1994; Boxerman
et al, 1995; Tropres et al, 2001):
BV ¼
3
4p
DR 
2
gDwB0
ð1Þ
where g is the gyromagnetic ratio, Dw the susceptibility difference,
B0 the magnetic field in the absence of sample. For an injection of
AMI-227 of 200mmol of iron per kg, Dw was equal to 0.688 part per
million at 2.35T in large vessels (Tropres et al, 2001). Since
measurements were performed in brain microcirculation, Dw value
was corrected by the ratio of haematocrit between brain
microcirculation and large vessels that corresponded to 0.83
(Bereczki et al, 1993). This resulted in a Dw value of 0.571 (Payen
et al, 1998). We also assumed that the brain haematocrit remains
constant during hypoxic hypoxia, as previously shown in most
brain areas (Bereczki et al, 1993). Regional BV is expressed as the
fractional blood volume in each voxel, or in ml100g
 1 tissue.
For each FiO2 episode, T2* maps were calculated by a least-
squares monoexponential fit of the signal intensity vs the echo
time on a pixel by pixel basis. Differences in relaxation rates in
each pixel were then calculated according to the formula:
DR 
2 ¼
1
T2pre
   
1
T2post
  ð2Þ
with T2pre* and T2post* are the relaxation times before and after
administration of the contrast agent, respectively. The DR2* values
were measured during the six successive FiO2 episodes. Three
regions of interest (ROI) were defined on the T2*-weighted images
(first echo) acquired at FiO2 of 0.10 (Figure 2): peritumoral region
(E192 pixels) corresponding to the hyposignal at the edge of the
tumour on the T2*-weighted images, intratumoral region (E62
pixels) corresponding to hypersignal inside the tumour on the T2*-
weighted images and contralateral (striatum) region (E44 pixels).
Pixels with excessive DR2* values (4200s
 1), that is, BV larger
than 13.3ml.100g
 1, during any FiO2 episode were discarded
(Figure 3B). This threshold corresponds to the upper limit of
validity of the linear relationship between DR2* and BV. Selection
of the ROI was made at FiO2 of 0.10 because it corresponded to the
highest number of pixels to be discarded. A correction for
clearance of the contrast agent from the plasma (elimination half-
time E4.5h) was applied since the postcontrast experiments lasted
E75min. This correction has been described elsewhere (Payen
et al, 1998).
Histological study
Two groups of excised brains were sliced in horizontal plane using
a cryotome (10mm thick). The first group included all rat brains
studied by MRI. A total of 24 brain sections located in the MRI
slice were obtained every 250mm. Haematoxylin erythrosin safran
(HES) staining was used to characterise the brain tumour
(localisation, size and regions). In the second group of excised
brains (rats excluded from the MRI study due to the physiological
inclusion criteria), three adjacent brain sections were obtained
from the largest tumour surface. One of these sections was stained
using HES to characterise brain tumour. Another brain section was
immunostained using goat anti-collagen primary antibody (1:100;
1h at 41C) (Southern Biotechnology Associates, Birmingham, AL,
USA) and biotinylated anti-goat secondary antibody (1:500;
30min at room temperature) (Santa Cruz Biotechnology, Santa
Cruz, CA, USA) to identify mature and immature brain vessels.
The last brain section was immunostained using mouse anti-a
smooth muscle actin (a-SMA) primary antibody (1:500; 1h at
41C) (Dako, Glostrup, Denmark) and biotinylated anti-mouse
secondary antibody (1:1000; 30min at room temperature)
(Valbiotech, Paris, France) to identify immature brain vessels.
Biotinylated antibodies were detected using extravidin-peroxidase
(1:1000; 30min at room temperature) (Sigma-Aldrich, Saint-
Quentin Fallavier, France). The sections were rinsed three times
with phosphate-buffered saline (Sigma-Aldrich, Saint-Quentin
Fallavier, France) between incubations. The sections were analysed
using an optical microscope at low and high magnification ( 100
Figure 2 Regions of interest (ROI) defined on T2*-weighted images: peritumoral (p), intratumoral (i) and contralateral (c) regions. The T2*-weighted
images (first echo) acquired at FiO2 of 0.10 (A) were used to select ROI (B).
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sand  200). Histological analysis was qualitative and allowed
verification of brain tumour growth, confirmation of the ROI
selection made for MRI analysis, and documentation of tumour
vascular architecture.
Statistical analysis
Data are expressed as mean7s.d. Analysis for statistical sig-
nificance of changes during the successive episodes was performed
using one-way analysis of variance (ANOVA) for repeated
measurements (StatView SE program, Abacus Concepts Inc.,
California, USA). To examine regional differences in the response
to hypoxia, interaction between brain regions and episodes was
assessed using two-way ANOVA (ROI FiO2 episodes) for
repeated measurements. Each value at a given episode was
compared to that obtained at another episode using the Scheffe ´
post hoc test. Difference in BV between brain regions at each FiO2
episode was tested using a one-way ANOVA for repeated
measurements. Peritumoral and intratumoral regions were com-
pared to the contralateral values using the Scheffe ´ post hoc test.
Statistical significance threshold was P¼0.05.
RESULTS
Of the 26 rats, 17 were excluded from the MRI study for the
following reasons: MABP o100mmHg, Hb o10gdl
 1 or pHa
o7.30 during control episode (n¼5); MABP o70mmHg, PaCO2
o27mmHg or pHa o7.30 during hypoxia episodes (n¼9),
absence of brain tumour (n¼3). Therefore, the cerebrovascular
response to graded hypoxic hypoxia was investigated in nine rats
with brain glioma.
Physiological data are shown in Table 1. Hypoxic hypoxia
caused a significant decrease in MABP and hypocapnia at FiO2 of
0.10. All parameters returned to control value during reoxygena-
tion episode. Changes in pHa or in Hb were not observed
throughout the study.
Typical DR2* images are shown in Figure 3A. Administration of
the contrast agent resulted in decrease of the T2* values, leading to
positive DR2* in the brain. The largest DR2* values (corresponding
to high BV) were observed in the peritumoral region. The lowest
DR2* values were observed in the intratumoral region. Excluded
pixels (BV413.3ml.100g
 1) were mainly observed in the peritu-
moral region at FiO2 of 0.35 (Figure 3B). As FiO2 was decreased,
the number of pixels excluded increased, reaching a maximum at
FiO2 of 0.10.
There was a significant interaction between brain regions and
FiO2 episodes (F¼5.19; Po0.01), meaning that a regional
difference was found in the response to hypoxia. Interfactor
analysis showed that peritumoral BV (3.470.7ml.100g
 1) was
significantly higher than contralateral (2.270.6ml.100g
 1) and
intratumoral (1.171.4ml.100g
 1) BV during the control episode.
In addition, the peritumoral region had a significantly higher BV
Table 1 Physiological parameters of tumour-bearing rats (n¼9), at each FiO2 level
a
Control Normoxia 0.15 0.12 0.10 Reoxygenation
MABP (mmHg) 115720 120715 95715 90720 65720
b 125725
PaO2 (mmHg) 144.6716.2 111.2714.0
b 56.575.8
b 41.874.1
b 35.472.8
b 154.1719.0
SaO2 (%) 99.271.5 94.475.7 74.175.6
b 55.275.4
b 43.173.9
b 98.972.4
PaCO2 (mmHg) 36.072.6 35.974.8 32.672.2 31.172.5 28.173.3
b 34.072.6
Pha 7.3470.03 7.3570.03 7.3970.02 7.3970.02 7.3770.07 7.3470.07
Hb (g/dl) 13.670.9 13.371.3 13.370.2 13.170.7 12.570.9 12.970.7
aEvolution of mean arterial blood pressure (MABP), arterial blood gases (PaO2 and PaCO2), arterial saturation of haemoglobin in oxygen (SaO2), arterial pH (pHa) and
haemoglobin content (Hb) at each episode of FiO2 (mean7s.d.).
bPo0.05 compared to control value (Scheffe ´ F-test).
Figure 3 (A) Example of DR2* maps for control episode (FiO2 of 0.35), normoxia episode (FiO2 of 0.25), hypoxia episodes (FiO2 of 0.15, 0.12, 0.10) and
reoxygenation episode (Reox, FiO2 of 0.35). (B) Pixels discarded from BV measurement because of excessive DR2* values.
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sthan the contralateral region for each FiO2 episode, apart from
FiO2 of 0.10 (Figure 4). The peritumoral and contralateral regions
exhibited a significant graded increase in BV during hypoxia, with
the greatest degree of hypoxia (FiO2 of 0.10) yielding to the largest
BV increase. Contralateral BV increases were 28714% of control
value at FiO2 of 0.12, and 49722% at FiO2 of 0.10. Peritumoral BV
increases were 19712% of the control value at FiO2 of 0.12, and
28717% at the FiO2 episode of 0.10. These changes were reversed
during reoxygenation, and the BV returned to control values in the
contralateral and the peritumoral regions. It should be noted that
no difference in BV changes was found between these two regions
during the successive FiO2 episodes, including reoxygenation.
A large intervariability in absolute BV values and in BV changes
was noted in the intratumoral region (Figure 4). Intratumoral BV
significantly increased only at a FiO2 of 0.10 (þ1867253% of
control values), although the absolute BV values were significantly
lower than the contralateral BV at this level of hypoxia. Moreover,
no evidence of return toward control values was found in this
region during the reoxygenation.
Histological analysis confirmed that the C6 glioma developed
at the expense of striatal tissue. The size of the brain tumour
was not different between the rats. The peritumoral region in
the MRI experiment corresponded to the limit between normal
tissue and viable, non-necrotic, intratumoral tissue. Collagen and
a-SMA staining were used to qualitatively assess the number
and morphology of all vessels and of the smooth muscle cells
and pericytes characterising mature vessels respectively (Figure 5).
In the peritumoral tissue, there were numerous vessels,
mostly stained using a-SMA. In the intratumoral region, few,
large and tortuous vessels with no a-SMA staining were depicted
in the viable tumour tissue. There were no vessels in the
necrotic areas.
DISCUSSION
Using the in vivo measurement of regional BV in a model of
rat brain glioma, we found a comparable vascular response to
graded hypoxic hypoxia of the peritumoral and contralateral
regions. Combined with the histological study showing a-SMA
staining in the peritumoral region, these findings indicate that
vessels in this region present intact vasoreactivity. Similar results
using MRI and SMA staining were reported in a model of
subcutaneous tumour exposed to hypercapnia (Abramovitch et al,
1999). This vascular reactivity could be taken advantage of to
improve the delivery of antitumoral agent through the increase of
local blood flow.
Some experimental points need to be addressed. First, despite
epinephrine, the highest level of hypoxic hypoxia (FiO2 of 0.10)
was associated with hypocapnia and with a decrease in
MABP, which a priori, might interfere with BV changes. However,
as discussed elsewhere (Julien-Dolbec et al, 2002), the influence
of these two parameters on BV changes is likely minor
compared to that of severe hypoxia hypoxia, and should not
invalid the comparison between regions of the response to
hypoxia. Second, the relationship between DR2* and BV postulates
that the contrast agent must be confined within the vascular space.
This particular point has been addressed by Dennie et al
(1998), who showed that DR2* did not change in rat brain tumour
during 90min following the administration of a contrast agent
(MION) very similar to the present one (AMI-227/Sienerem
s).
Since our experiment lasted about 75min, we considered that
the contrast agent extravasation was negligible, regardless the
status of the blood–brain barrier. The restoration of BV
measurements to control values during the reoxygenation period
suggests that extravasation does not occur in peritumoral region.
Conversely, a leakage of contrast agent in tumoral region cannot
be definitively ruled out.
The difference in the control values between the three brain
regions can be due to a difference in their vessel density. Indeed,
the large BV value found in the peritumoral region agrees with the
high density of vessels reported by others (Deane and Lantos, 1981;
Luthert and Lantos, 1985; Dennie et al, 1998; Peoc’h et al, 1999).
Conversely, the low BV values found in the intratumoral region are
consistent with the presence both of viable tumour tissue with few
vessels and necrosis without vessels. A quantitative study was
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Figure 4 Evolution of blood volume (BV, in ml100g
 1 of brain tissue) in peritumoral, intratumoral and contralateral regions during graded hypoxic
hypoxia and reoxygenation (n¼9). Peritumoral and contralateral BV were reversibly increased during moderate hypoxia (FiO2 0.12) while intratumoral BV
was irreversibly increased during severe hypoxia (FiO2 0.10). *Po0.05 between FiO2 compared to control value (Scheffe ´ F-test). Peritumoral region had a
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spreviously conducted to explore vessel density in the same model
of rat brain tumour (Peoc’h et al, 1999), and our results are in
agreement with this quantitative study. However, our control
values of BV in the contralateral region (2.270.6ml.100g
 1) were
notably smaller than those found in normal rat striatum using the
same technique (3.170.7ml.100g
 1) (Julien-Dolbec et al, 2002).
Similar findings concerning local cerebral blood flow were noted
between normal rats and rats with brain glioma (Aizawa et al,
1990). These differences could be due to a tumour-related
compression of surrounding tissues, particularly during the late
stage of tumour growth.
It is established that hypoxic hypoxia is accompanied in the
healthy brain by an increase in cerebral blood flow (Koehler et al,
1984). This increase is due to dilation of the cerebral arterioles
(Kontos et al, 1978). Considering that pixels with high BV (i.e.,
BV413.3ml.100g-1) were excluded (see Materials and Methods
section), the present changes in BV in the contralateral tissue
should involve parenchymal arterioles and venules. The BV
response to hypoxic hypoxia in this region (þ28714% of control
value at FiO2 of 0.12) was close to that reported in normal rats
(þ38725%) (Julien-Dolbec et al., 2002).
In brain tumour, there is a large heterogeneity in vessel
morphology (number, size, connections). Previous studies
(Abramovitch et al, 1999; Holash et al, 1999) indicated however
that vessels located between normal and tumoral tissue
have mostly a-smooth muscle actin staining (as also shown in
this study) and thus correspond to mature pre-existing vessels.
Our results, showing comparable hypoxia-induced changes in
BV in the peritumoral and the contralateral regions, are in line
with these in vitro findings. Conversely, intratumoral tissue
contains immature vessels and/or necrosis. The large, tortuous
vessels with no a-smooth muscle actin likely correspond to
angiogenesis-induced neovessels (Deane and Lantos, 1981; Zama
et al, 1991). In the present study, a significant change in
intratumoral BV was found during severe hypoxic hypoxia
(FiO2 of 0.10) only, with no return towards control values
during reoxygenation. This can be explained by a possible
extravasation of the contrast agent and/or a passive, hypoxic-
induced vasodilation resulting from surrounding vasodilated
tissue (Robinson et al, 1999). The large variability in BV values
and BV changes in this region may be ascribed to a redistribution
of the perfusion within the tumour (Dewhirst et al, 1989;
Kuperman et al, 1995).
In conclusion, our study shows that the vascular response to a
vasodilating stimulus such as hypoxic hypoxia can be measured in
vivo in a model of rat brain glioma. Peritumoral vessels had a
response to hypoxic hypoxia that was comparable to that from
normal vessels. Susceptibility contrast MRI is an appropriate
method for noninvasively demonstrating whether any particular
vascular-modifying strategy results in the desired outcome in
terms of tumour blood volume changes.
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Figure 5 Immunohistochemistry detection in rat brain tumour in 1 contralateral, 2 peritumoral (at the border between normal and viable tumour
tissues) and 3 intratumoral (viable tumour tissue near necrosis) regions. Histological staining was performed by HES. All vessels were stained using anti-
collagen antibody (COL) and mature vessels were stained using anti-a smooth muscle actin antibody (SMA). Some vessels in the peritumoral region
exhibited both COL and SMA staining (indicated by arrows) suggesting reactive vessels to hypoxic hypoxia.
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